In Case You Missed It: Top 10 Gray Sheet Stories In March
This article was originally published in The Gray Sheet
A story covering the latest details on FDA's Office of Regulatory Affairs wholesale restructuring was the most popular Gray Sheet item last month, followed by a piece with tips on regaining FDA's trust. There was also significant interest in our coverage of the closely watched Vascular Solutions off-label case, challenges for notified bodies in Europe, Senate action, user-fee negotiations, and more.
Register for our free email digests: